Skip to main content
Log in

X-ray crystallographic and theoretical studies of substituted phenyl 3,5-di[N-methyl] carbamoyl-1,4-dihydropyridines: Targets for Ca2+ antagonist

  • Published:
Journal of Chemical Crystallography Aims and scope Submit manuscript

Abstract

A series of 4(x-substituted phenyl)-1,4-dihydropyridines (x=2—CF3 (1), 2-CH3 (2), 2-OCH3 (3) and 2,4-Cl (4)) with a new substituent, the N-methylcarbamoyl (CONHCH3) group at C3 and C5 are crystallographically characterized and a comparison has been made with important conformational parameters obtained theoretically. The dihydropyridine rings are in shallow boat conformation. The phenyl substituent orientation is synperiplanar. Both the carbonyl groups are oriented anticlinal in 1, 2 and 3; but in 4, one is synclinal and the other synperiplanar with the adjacent double bond. The presence of solvent molecules in 1 (CH3OH), 2 (CH3OH), and 3 (H2O) has significantly changed the hydrogen bonding pattern. Theoretical studies at the semiempirical AM1 MO level reproduces the general features of the structures. The near planarity of the DHP ring and the orientation of the phenyl substituent make 1 and 2 encouraging targets for pharmacological, study. Crystallographic Data:1: a = 8.793(2), b = 29.962(5), c = 8.215(2) Å, β = 115.28(2)°, Monoclinic, P21/c; 2: a = 8.799(2), b = 15.789(3), c = 14.074(2) Å, β = 100.25(2)°, Monoclinic, P21/n; 3: a = 8.347(1), b = 8.986(1), c = 13.749(2) Å, α = 97.50(1), β = 94.78(1), γ = 101.38(1)° Triclinic, P4: a = 12.928(3), b = 14.506(3), c = 9.740(2) Å, Orthorhombic, Pca21.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Janis, R.A.; Silver, F.J.; Triggle, D.J. Adv. Drug. Res. 1987, 16, 309.

    Google Scholar 

  2. Speeding, M.; Paoletti, R. Pharm. Rev. 1992, 44, 363.

    Google Scholar 

  3. Triggle, D.J.; Rampe, R. Trends Pharmacol. Sci. 1989, 10, 507.

    Google Scholar 

  4. Fleckenstein, A. Annu. Rev.Pharmacol. Toxicol. 1977, 17, 149.

    Google Scholar 

  5. Reuter, H. Nature 1983, 301, 569.

    Google Scholar 

  6. Janis, R.A.; Tiggle, D.J. J. Med. Chem. 1983, 26, 775.

    Google Scholar 

  7. Schramm, M.; Thomas, G.; Towart, R.; Franckowiak, G. Nature 1983, 303, 535.

    Google Scholar 

  8. Troug, A.G. Presentation at the 67th Annual Meeting of The federation of American Societies for Experimental Biology, Chicago, 1983.

  9. Langs, D.A.; Triggle, D.J. Mol. Pharmacol. 1985, 27, 544.

    Google Scholar 

  10. Loev, B.; Goodman, M.M.; Snader, K.M.; Tedeschi, R.; Macko, E. J. Med. Chem. 1974, 17, 956.

    Google Scholar 

  11. Coburn, R.A.; Wierzba, M.; Suto, M.J.: Solo, A.J.; Triggle, A.M.; Triggle, D.J. J. Med. Chem. 1988, 31, 2103.

    Google Scholar 

  12. Goldmann, S.; Stoltefuss, J. Angew. Chem. Int. Ed. Engl. 1991, 30, 1559.

    Google Scholar 

  13. Triggle, D.J.; Langs, D.A.; Janis, R.A. Med. Res. Rev. 1989, 9, 123.

    Google Scholar 

  14. Fossheim, R. J. Med. Chem. 1986, 29, 305.

    Google Scholar 

  15. Mahmoudian, M.; Richards, W.G. J. Pharm. Pharmacol. 1986, 38, 272.

    Google Scholar 

  16. Mahmoudian, M.; Richards, W.G. J. Chem. Soc. Commun. 1986, 739.

  17. Sadanandam, Y.S.; Shetty, M.M.; Reddy, K.R.M.; Leelavati, P. Eur. J. Med. Chem. 1994, 29, 975.

    Google Scholar 

  18. Sheldrick, G.M. SHELXTL-Plus Revision 4.11/V. Siemens Analytical X-ray Instruments, Inc.: Madison, WI, 1991.

    Google Scholar 

  19. Nardelli, M. Comput. Chem. 1983, 7, 95.

    Google Scholar 

  20. Fossheim, R.; Svarteng, K.; Mostad, A.; Romming, C.; Shefter, E.; Triggle, D.J. J. Med. Chem. 1982, 25, 126.

    Google Scholar 

  21. Fossheim, R.; Acta Chem. Scand. 1985, B39, 785.

    Google Scholar 

  22. Duax, W.L.; Norton, D.A. Atlas of Steroid Structure, Vol. II; New York: Plenum, 1975.

    Google Scholar 

  23. Triggle, A.M.; Shefter, E.; Triggle, D.J. J. Med. Chem. 1980, 23, 1442.

    Google Scholar 

  24. Stewart, J.J.P. MOPAC 93.00 Manual; Fujitsu Limited: Tokyo, Japan, 1993.

    Google Scholar 

  25. Ishida, M.; Hamada, T.; Fujishita, Y.; Saito, Y.; Ohkubo, K. Bull. Chem. Soc. Jpn. 1993, 66, 714.

    Google Scholar 

  26. Present work.

  27. Fonesca, I.; Martinez-Carrera, S.; Garcia-Blanco, S. Acta Crystallogr. 1986, C42, 1792.

    Google Scholar 

  28. Rowan, K.R.; Holt, E.M. Acta Crystallogr. 1996, C52, 1565.

    Google Scholar 

  29. Rowan, K.R., Holt, E.M. Acta Crystallogr. 1996, C52, 2207.

    Google Scholar 

  30. Mehdi, S.; Ravikumar, K. Acta Crystallogr. 1992, C48, 1627.

    Google Scholar 

  31. Palmer, R.B.; Anderson, N.H. Bioorg. Med. Chem. Lett. 1996, 18, 2173.

    Google Scholar 

  32. Hempel, A.; Gupta, M.P. Acta Crystallogr. 1978, B34, 3815.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Sagar, M.B., Ravikumar, K., Mehdi, S. et al. X-ray crystallographic and theoretical studies of substituted phenyl 3,5-di[N-methyl] carbamoyl-1,4-dihydropyridines: Targets for Ca2+ antagonist. Journal of Chemical Crystallography 29, 481–491 (1999). https://doi.org/10.1023/A:1009579430593

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/A:1009579430593

Navigation